Synthesis of conjugated (1E,3E)- and (1Z,3Z)-1,4-di(n-pyridyl) (or n-quinolyl)-1,3-butadienes from n-(2'-chloroethenyl)pyridine (or quinoline)RODRIGUEZ, J. G; DIAZ-OLIVA, Cristina.Tetrahedron (Oxford. Print). 2009, Vol 65, Num 12, issn 0040-4020, 2381, 2512-2517 [7 p.]Article

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab : updated efficacy and biomarker analysesCAMERON, David; CASEY, Michelle; CHAN, Arlene et al.Breast cancer research and treatment. 2008, Vol 112, Num 3, pp 533-543, issn 0167-6806, 11 p.Article

Mitogen-Activated Protein Kinase Phosphatase-1 in Human Breast Cancer Independently Predicts Prognosis and Is Repressed by DoxorubicinROJO, Federico; GONZALEZ-NAVARRETE, Irene; SANCHEZ-PEREZ, Isabel et al.Clinical cancer research (Print). 2009, Vol 15, Num 10, pp 3530-3539, issn 1078-0432, 10 p.Article

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast CancerLIN, Nancy U; DIERAS, Véronique; LOIBL, Sibylle et al.Clinical cancer research (Print). 2009, Vol 15, Num 4, pp 1452-1459, issn 1078-0432, 8 p.Article

HER-2 Gene Amplification, HER-2 and Epidermal Growth Factor Receptor mRNA and Protein Expression, and Lapatinib Efficacy in Women with Metastatic Breast CancerPRESS, Michael F; FINN, Richard S; DANENBERG, Kathy et al.Clinical cancer research (Print). 2008, Vol 14, Num 23, pp 7861-7870, issn 1078-0432, 10 p.Article

Lapatinib plus capecitabine for HER2-positive advanced breast cancerGEYER, Charles E; FORSTER, John; SKARLOS, Dimosthenis et al.The New England journal of medicine. 2006, Vol 355, Num 26, pp 2733-2743, issn 0028-4793, 11 p.Article

Randomized Trial of Lapatinib Versus Placebo Added to Paclitaxel in the Treatment of Human Epidermal Growth Factor Receptor 2―Overexpressing Metastatic Breast CancerZHONGZHEN GUAN; BINGHE XU; LIM LEUNG, Wai et al.Journal of clinical oncology. 2013, Vol 31, Num 16, pp 1947-1953, issn 0732-183X, 7 p.Article

Estrogen Receptor, Progesterone Receptor, Human Epidermal Growth Factor Receptor 2 (HER2), and Epidermal Growth Factor Receptor Expression and Benefit From Lapatinib in a Randomized Trial of Paclitaxel With Lapatinib or Placebo As First-Line Treatment in HER2-Negative or Unknown Metastatic Breast CancerFINN, Richard S; PRESS, Michael F; DERING, Judy et al.Journal of clinical oncology. 2009, Vol 27, Num 24, pp 3908-3915, issn 0732-183X, 8 p.Article

Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor-Positive Metastatic Breast CancerJOHNSTON, Stephen; PIPPEN, John; PRESS, Michael F et al.Journal of clinical oncology. 2009, Vol 27, Num 33, pp 5538-5546, issn 0732-183X, 9 p.Article

Diastereoselective synthesis and estimation of the conformational flexibility of 6-oxoperhydropyridazine-3-carboxylic acid derivativesALVAREZ-IBARRA, Carlos; CSAK, Aurelio G; GOMEZ DE LA OLIVA, Cristina et al.Journal of organic chemistry. 2002, Vol 67, Num 9, pp 2789-2797, issn 0022-3263Article

A pharmacokinetic, pharmacodynamic, and electrocardiographic study of liposomal mifamurtide (L-MTP-PE) in healthy adult volunteersVENKATAKRISHNAN, Karthik; KRAMER, William G; SYNOLD, Timothy W et al.European journal of clinical pharmacology. 2012, Vol 68, Num 10, pp 1347-1355, issn 0031-6970, 9 p.Article

Pooled analysis of diarrhea events in patients with cancer treated with lapatinibCROWN, John P; BURRIS, Harold A; CHAN, Steve et al.Breast cancer research and treatment. 2008, Vol 112, Num 2, pp 317-325, issn 0167-6806, 9 p.Article

Phase III, Double-Blind, Randomized Study Comparing Lapatinib Plus Paclitaxel With Placebo Plus Paclitaxel As First-Line Treatment for Metastatic Breast CancerDI LEO, Angelo; GOMEZ, Henry L; WILLIAMS, Lisa S et al.Journal of clinical oncology. 2008, Vol 26, Num 34, pp 5544-5552, issn 0732-183X, 9 p.Article

Interleukin 6, a nuclear factor-κB target, predicts resistance to docetaxel in hormone-independent prostate cancer and nuclear factor-κB inhibition by PS-1145 enhances docetaxel antitumor activityDOMINGO-DOMENECH, Josep; OLIVA, Cristina; ROLFE, Mark et al.Clinical cancer research. 2006, Vol 12, Num 18, pp 5578-5586, issn 1078-0432, 9 p.Article

The role of the surrounding polarity on the phototautomerization process in a diazaaromatic compound: An UV-vis and NMR studyREYMAN, Dolores; MONTORO, Teresa; VINAS, Montserrat H et al.Journal of luminescence. 2014, Vol 148, pp 64-71, issn 0022-2313, 8 p.Article

Cholangitis caused by biliary hydatidosisGUARNER-ARGENTE, Carlos; GOMEZ-OLIVA, Cristina; POCA, Maria et al.Gastrointestinal endoscopy (Print). 2010, Vol 72, Num 6, pp 1264-1266, issn 0016-5107, 3 p.Article

Highly Enantioselective 1,4-Michael Additions of Nucleophiles to Unsaturated Aryl Ketones with Organocatalysis by Bifunctional Cinchona AlkaloidsOLIVA, Cristina G; SILVA, Artur M. S; RESENDE, Diana I. S. P et al.European journal of organic chemistry (Print). 2010, Num 18, pp 3449-3458, issn 1434-193X, 10 p.Article

Partially covered self-expanding metal stent for unresectable malignant extrahepatic biliary obstruction: results of a large prospective seriesGOMEZ-OLIVA, Cristina; GUARNER-ARGENTE, Carlos; CONCEPCION, Mar et al.Surgical endoscopy. 2012, Vol 26, Num 1, pp 222-229, issn 0930-2794, 8 p.Article